A randomised trial of point-of-care tests for chlamydia and gonorrhoea infections in remote Aboriginal communities: Test, Treat ANd GO- the “TTANGO” trial protocol
A randomised trial of point-of-care tests for chlamydia and gonorrhoea infections in remote Aboriginal communities: Test, Treat ANd GO- the “TTANGO” trial protocol
BMC Infectious Diseases
- Author(s): Guy, Rebecca J., Natoli, Lisa, Ward, James, Causer, Louise, Hengel, Belinda, Whiley, David, Tabrizi, Sepehr N., Donovan, Basil, Fairley, Christopher K., Badman, Steven B., Tangey, Annie, Wand, Handan, Shephard, Mark, Regan, David G., Wilson, David, Anderson, David, Kaldor, John M.
- Published: 2013
- Volume: 13
- ISBN: 1471-2334
Abstract: High prevalence rates of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) have been reported in Aboriginal people in remote and regional areas of Australia for well over two decades, and repeat positivity rates are high. To interrupt disease transmission and reduce the risk of complications, early diagnosis and treatment is important. However in many remote and regional areas there are long delays between testing for these curable sexually transmissible infections and providing treatment, due to both physical distance from laboratories and difficulties when recalling patients for subsequent management once results are available. Point-of-care (POC) tests have the potential to provide more timely diagnosis, to increase treatment and contact tracing, and in turn reduce CT and NG infection rates.